Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease
- 28 February 2005
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 375 (2) , 112-116
- https://doi.org/10.1016/j.neulet.2004.10.078
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Tau gene and Parkinson's disease: a case-control study and meta-analysisJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Further evidence that interactions between CYP2D6 and pesticide exposure increase risk for Parkinson's diseaseAnnals of Neurology, 2004
- Tau haplotypes regulate transcription and are associated with Parkinson's diseaseAnnals of Neurology, 2004
- Functional analysis of intra-allelic variation at NACP-Rep1 in the ?-synuclein geneHuman Genetics, 2003
- Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter systemHuman Molecular Genetics, 2001
- alpha-synuclein gene haplotypes are associated with Parkinson's diseaseHuman Molecular Genetics, 2001
- Parkinson's disease is not associated with the combined α‐synuclein/apolipoprotein E susceptibility genotypeAnnals of Neurology, 2001
- Genetic studies in Parkinson's disease with an α-synuclein/NACP gene polymorphism in JapanNeuroscience Letters, 2001
- Increased susceptibility to sporadic Parkinson's disease by a certain combined ?-synuclein/apolipoprotein E genotypeAnnals of Neurology, 1999
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998